gentamicin has been researched along with Community Acquired Infection in 44 studies
Gentamicins: A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This retrospective observational study including patients with community-acquired sepsis or septic shock and positive blood cultures, who meet Sepsis-3 criteria, shows that the addition of one single dose of gentamicin to β-lactam treatment at admittance was associated with a decreased risk of mortality and was not associated with AKI." | 7.96 | Antibiotic treatment with one single dose of gentamicin at admittance in addition to a β-lactam antibiotic in the treatment of community-acquired bloodstream infection with sepsis. ( Fredlund, H; Källman, J; Liljedahl Prytz, K; Magnuson, A; Prag, M; Sundqvist, M, 2020) |
| " The purposes of this study were to investigate the clinical efficacy of gentamicin as an initial empirical antimicrobial agent and to evaluate the effects of gentamicin resistance on clinical outcomes in women with complicated non-obstructive acute pyelonephritis (APN)." | 7.80 | Effects of gentamicin monotherapy for the initial treatment of community-onset complicated non-obstructive acute pyelonephritis due to Enterobacteriaceae in elderly and non-elderly women. ( Chang, UI; Kim, HW; Wie, SH, 2014) |
| "The objectives of this study were to evaluate the clinical effectiveness of gentamicin as an initial empirical antimicrobial agent and to determine the effects of gentamicin resistance on clinical outcomes in women with uncomplicated acute pyelonephritis (APN)." | 7.79 | Use of gentamicin for women with community-acquired uncomplicated acute pyelonephritis caused by gentamicin-susceptible or -resistant Escherichia coli: 10-year experience. ( Chang, UI; Kim, HW; Wie, SH, 2013) |
| "On this basis, a study was conducted in a district hospital to study the therapy outcomes of antibiotic regimens used in pediatric community-acquired pneumonia (CAP) management and to conduct a cost-effectiveness analysis (CE) between IV ampicillin versus combination therapy of IV ampicillin and IV gentamicin." | 5.11 | A clinical and economic study of community-acquired pneumonia between single versus combination therapy. ( Ahmad, Z; Hasali, JB; Hasali, MA; Ibrahim, MI; Sulaiman, SA, 2005) |
| "This retrospective observational study including patients with community-acquired sepsis or septic shock and positive blood cultures, who meet Sepsis-3 criteria, shows that the addition of one single dose of gentamicin to β-lactam treatment at admittance was associated with a decreased risk of mortality and was not associated with AKI." | 3.96 | Antibiotic treatment with one single dose of gentamicin at admittance in addition to a β-lactam antibiotic in the treatment of community-acquired bloodstream infection with sepsis. ( Fredlund, H; Källman, J; Liljedahl Prytz, K; Magnuson, A; Prag, M; Sundqvist, M, 2020) |
| " The purposes of this study were to investigate the clinical efficacy of gentamicin as an initial empirical antimicrobial agent and to evaluate the effects of gentamicin resistance on clinical outcomes in women with complicated non-obstructive acute pyelonephritis (APN)." | 3.80 | Effects of gentamicin monotherapy for the initial treatment of community-onset complicated non-obstructive acute pyelonephritis due to Enterobacteriaceae in elderly and non-elderly women. ( Chang, UI; Kim, HW; Wie, SH, 2014) |
| "The objectives of this study were to evaluate the clinical effectiveness of gentamicin as an initial empirical antimicrobial agent and to determine the effects of gentamicin resistance on clinical outcomes in women with uncomplicated acute pyelonephritis (APN)." | 3.79 | Use of gentamicin for women with community-acquired uncomplicated acute pyelonephritis caused by gentamicin-susceptible or -resistant Escherichia coli: 10-year experience. ( Chang, UI; Kim, HW; Wie, SH, 2013) |
| "To study the clonality of gentamicin-resistant, extended-spectrum beta-lactamase (ESBL)-negative and ESBL-producing Escherichia coli isolated from community-onset urinary tract infections (UTIs) in Cornwall." | 3.74 | Molecular epidemiology of multiresistant Escherichia coli isolates from community-onset urinary tract infections in Cornwall, England. ( Hartley, JW; Karisik, E; Kaufmann, ME; Woodford, N, 2007) |
| " The clinical picture of a "typical" bacterial pneumonia in the three patients led to an initial empirical treatment with amoxicillin clavulanic acid or 2(nd) generation cephalosporins." | 3.69 | Severe community-acquired pneumonia caused by atypical organisms. ( Huyghens, L; Lauwers, S; Meysman, M; Monsieur, I; Vincken, W, 1997) |
| "Possible serious bacterial infection was diagnosed in 704 infants, among 5766 screened." | 2.77 | Community-based treatment of serious bacterial infections in newborns and young infants: a randomized controlled trial assessing three antibiotic regimens. ( Bhutta, ZA; Darmstadt, GL; Sultana, S; Thaver, D; Tikmani, SS; Warraich, HJ; Zaidi, AK, 2012) |
| " The adverse event rate was non-significantly lower in the piperacillin/ tazobactam group compared to the co-amoxiclav/aminoglycoside group (2% vs." | 2.69 | Efficacy, safety, and tolerance of piperacillin/tazobactam compared to co-amoxiclav plus an aminoglycoside in the treatment of severe pneumonia. ( Grossenbacher, M; Imhof, E; Speich, R; Vogt, M; Zimmerli, W, 1998) |
| "Community acquired bacterial meningitis due to extended spectrum β lactamase-producing Escherichia coli is very rare." | 2.48 | [Case of an elderly patient with community acquired bacterial meningitis due to extended spectrum β lactamase producing Escherichia coli]. ( Gon, Y; Hara, H; Murase, S; Nakazawa, K; Otsubo, R; Park, K, 2012) |
| " In conclusion, gentamicin is safe and has similar outcomes to alternative Gram-negative antimicrobial regimens for empirical coverage in severe CAP patients admitted to the ICU." | 1.48 | Is gentamicin safe and effective for severe community-acquired pneumonia? An 8-year retrospective cohort study. ( Brereton, CJ; Browning, S; Davis, JS; Dunn, E; Ferguson, JK; Lennon, D, 2018) |
| "The renal safety of gentamicin has been questioned even when dosed once daily." | 1.37 | Short-term gentamicin therapy and risk of renal toxicity in patients with bacteraemia. ( Hønge, BL; Nielsen, H; Schønheyder, HC; Spanggaard, MH, 2011) |
| "Trovafloxacin was 2-4 times more active than ciprofloxacin against both groups of strains." | 1.31 | Resistance to vancomycin, LY333328, ciprofloxacin and trovafloxacin of community-acquired and nosocomial strains of Enterococcus faecalis isolated in Badajoz (Spain) with and without high-level resistance to streptomycin and gentamicin. ( Blanco, MT; Gómez-García, AC; Hurtado, C; Morán, FJ; Pérez-Giraldo, C; Sánchez-Silos, RM, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (18.18) | 18.2507 |
| 2000's | 16 (36.36) | 29.6817 |
| 2010's | 18 (40.91) | 24.3611 |
| 2020's | 2 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Mustapha, SS | 1 |
| Ibrahim, M | 1 |
| Aliyu, S | 1 |
| Abdulkadir, I | 1 |
| Liljedahl Prytz, K | 1 |
| Prag, M | 1 |
| Fredlund, H | 1 |
| Magnuson, A | 1 |
| Sundqvist, M | 1 |
| Källman, J | 1 |
| Brereton, CJ | 1 |
| Lennon, D | 1 |
| Browning, S | 1 |
| Dunn, E | 1 |
| Ferguson, JK | 1 |
| Davis, JS | 1 |
| Berild, AG | 1 |
| Erichsen, D | 1 |
| Berild, D | 1 |
| Roldan-Masedo, E | 1 |
| Sainz, T | 1 |
| Gutierrez-Arroyo, A | 1 |
| Gomez-Gil, RM | 1 |
| Ballesteros, E | 1 |
| Escosa, L | 1 |
| Baquero-Artigao, F | 1 |
| Méndez-Echevarría, A | 1 |
| Wie, SH | 2 |
| Kim, HW | 2 |
| Chang, UI | 2 |
| Odongo, CO | 1 |
| Anywar, DA | 1 |
| Luryamamoi, K | 1 |
| Odongo, P | 1 |
| Lodha, R | 1 |
| Kabra, SK | 1 |
| Pandey, RM | 1 |
| Margat, E | 1 |
| Dargère, S | 1 |
| Daurel, C | 1 |
| Fines-Guyon, M | 1 |
| Michon, J | 1 |
| Verdon, R | 1 |
| Cattoir, V | 1 |
| Castagnola, E | 1 |
| Bandettini, R | 1 |
| Ginocchio, F | 1 |
| Perotti, M | 1 |
| Masa, DL | 1 |
| Ciucci, A | 1 |
| Loy, A | 1 |
| Caviglia, I | 1 |
| Haupt, R | 1 |
| Guida, E | 1 |
| Pini Prato, A | 1 |
| Mattioli, G | 1 |
| Buffa, P | 1 |
| Lin, TY | 1 |
| Chan, MC | 1 |
| Yang, YS | 1 |
| Lee, Y | 1 |
| Yeh, KM | 1 |
| Lin, JC | 1 |
| Chang, FY | 1 |
| Sakran, W | 1 |
| Smolkin, V | 1 |
| Odetalla, A | 1 |
| Halevy, R | 1 |
| Koren, A | 1 |
| Gottlieb, T | 1 |
| Su, WY | 1 |
| Merlino, J | 1 |
| Cheong, EY | 1 |
| Amezyane, T | 1 |
| Abouzahir, A | 1 |
| El Kharrass, A | 1 |
| Bassou, D | 1 |
| Fatihi, J | 1 |
| Hammi, S | 1 |
| Mahassin, F | 1 |
| Ghafir, D | 1 |
| Ohayon, V | 1 |
| Cooke, FJ | 1 |
| Gkrania-Klotsas, E | 1 |
| Howard, JC | 1 |
| Stone, M | 1 |
| Kearns, AM | 1 |
| Ganner, M | 1 |
| Carmichael, AJ | 1 |
| Brown, NM | 1 |
| Contreras, GA | 1 |
| Pérez, N | 1 |
| Murphy, JR | 1 |
| Cleary, TG | 1 |
| Heresi, GP | 1 |
| Mera, RM | 1 |
| Suaya, JA | 1 |
| Amrine-Madsen, H | 1 |
| Hogea, CS | 1 |
| Miller, LA | 1 |
| Lu, EP | 1 |
| Sahm, DF | 1 |
| O'Hara, P | 1 |
| Acosta, CJ | 1 |
| Spanggaard, MH | 1 |
| Hønge, BL | 1 |
| Schønheyder, HC | 1 |
| Nielsen, H | 1 |
| Gon, Y | 1 |
| Otsubo, R | 1 |
| Murase, S | 1 |
| Park, K | 1 |
| Nakazawa, K | 1 |
| Hara, H | 1 |
| Zaidi, AK | 1 |
| Tikmani, SS | 1 |
| Warraich, HJ | 1 |
| Darmstadt, GL | 1 |
| Bhutta, ZA | 1 |
| Sultana, S | 1 |
| Thaver, D | 1 |
| Cullen, IM | 1 |
| Manecksha, RP | 1 |
| McCullagh, E | 1 |
| Ahmad, S | 1 |
| O'Kelly, F | 1 |
| Flynn, R | 1 |
| McDermott, TE | 1 |
| Murphy, P | 1 |
| Grainger, R | 1 |
| Fennell, JP | 1 |
| Thornhill, JA | 1 |
| Shelburne, SA | 1 |
| Musher, DM | 1 |
| Hulten, K | 1 |
| Ceasar, H | 1 |
| Lu, MY | 1 |
| Bhaila, I | 1 |
| Hamill, RJ | 1 |
| Munckhof, WJ | 1 |
| Kleinschmidt, SL | 1 |
| Turnidge, JD | 1 |
| Hasali, MA | 1 |
| Ibrahim, MI | 1 |
| Sulaiman, SA | 1 |
| Ahmad, Z | 1 |
| Hasali, JB | 1 |
| Venkatesan, A | 1 |
| Spalding, C | 1 |
| Speedie, A | 1 |
| Sinha, G | 1 |
| Rumbaugh, JA | 1 |
| Ramdani-Bouguessa, N | 1 |
| Bes, M | 1 |
| Meugnier, H | 1 |
| Forey, F | 1 |
| Reverdy, ME | 1 |
| Lina, G | 1 |
| Vandenesch, F | 1 |
| Tazir, M | 1 |
| Etienne, J | 1 |
| Woodford, N | 1 |
| Kaufmann, ME | 1 |
| Karisik, E | 1 |
| Hartley, JW | 1 |
| Shaked, H | 1 |
| Carmeli, Y | 1 |
| Schwartz, D | 1 |
| Siegman-Igra, Y | 1 |
| Yee-Guardino, S | 1 |
| Kumar, D | 1 |
| Abughali, N | 1 |
| Tuohy, M | 1 |
| Hall, GS | 1 |
| Kumar, ML | 1 |
| Asghar, R | 1 |
| Banajeh, S | 1 |
| Egas, J | 1 |
| Hibberd, P | 1 |
| Iqbal, I | 1 |
| Katep-Bwalya, M | 1 |
| Kundi, Z | 1 |
| Law, P | 1 |
| MacLeod, W | 1 |
| Maulen-Radovan, I | 1 |
| Mino, G | 1 |
| Saha, S | 1 |
| Sempertegui, F | 1 |
| Simon, J | 1 |
| Santosham, M | 1 |
| Singhi, S | 1 |
| Thea, DM | 1 |
| Qazi, S | 1 |
| Fazal, BA | 1 |
| Turett, GS | 1 |
| Chilimuri, SS | 1 |
| Mendoza, CM | 1 |
| Telzak, EE | 1 |
| Hendricks, MK | 1 |
| Senekal, M | 1 |
| Monsieur, I | 1 |
| Meysman, M | 1 |
| Vincken, W | 1 |
| Huyghens, L | 1 |
| Lauwers, S | 1 |
| Silverman, J | 1 |
| Thal, LA | 1 |
| Perri, MB | 1 |
| Bostic, G | 1 |
| Zervos, MJ | 1 |
| Speich, R | 1 |
| Imhof, E | 1 |
| Vogt, M | 1 |
| Grossenbacher, M | 1 |
| Zimmerli, W | 1 |
| Asumang, A | 1 |
| Goldsmith, AL | 1 |
| Dryden, M | 1 |
| Duke, T | 1 |
| Michael, A | 1 |
| Orrett, FA | 1 |
| Adderson, E | 1 |
| Pavia, A | 1 |
| Christenson, J | 1 |
| Davis, R | 1 |
| Leonard, R | 1 |
| Carroll, K | 1 |
| Nimmo, GR | 1 |
| Schooneveldt, J | 1 |
| O'Kane, G | 1 |
| McCall, B | 1 |
| Vickery, A | 1 |
| Fujita, N | 1 |
| Sánchez-Silos, RM | 1 |
| Pérez-Giraldo, C | 1 |
| Blanco, MT | 1 |
| Morán, FJ | 1 |
| Hurtado, C | 1 |
| Gómez-García, AC | 1 |
| Bates, DE | 1 |
| Beaumont, SJ | 1 |
| Baylis, BW | 1 |
4 reviews available for gentamicin and Community Acquired Infection
| Article | Year |
|---|---|
Antibiotics for community-acquired pneumonia in children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Chloramphenicol; Community-Acquired Infection | 2013 |
Empyema necessitans and acute osteomyelitis associated with community-acquired methicillin-resistant Staphylococcus aureus in an infant.
Topics: Anti-Bacterial Agents; Bacteremia; Ceftriaxone; Clindamycin; Combined Modality Therapy; Community-Ac | 2009 |
[Case of an elderly patient with community acquired bacterial meningitis due to extended spectrum β lactamase producing Escherichia coli].
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Escherichia coli; Esche | 2012 |
[Vancomycin-resistant enterococci (VRE)].
Topics: Ampicillin; Animals; Bacteremia; Community-Acquired Infections; Cross Infection; Drug Therapy, Combi | 2000 |
4 trials available for gentamicin and Community Acquired Infection
| Article | Year |
|---|---|
Community-based treatment of serious bacterial infections in newborns and young infants: a randomized controlled trial assessing three antibiotic regimens.
Topics: Anti-Bacterial Agents; Bacterial Infections; Ceftriaxone; Community-Acquired Infections; Female; Gen | 2012 |
A clinical and economic study of community-acquired pneumonia between single versus combination therapy.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Community-Acquired Infections; Cost-Benefit Analysis; Data | 2005 |
Chloramphenicol versus ampicillin plus gentamicin for community acquired very severe pneumonia among children aged 2-59 months in low resource settings: multicentre randomised controlled trial (SPEAR study).
Topics: Ampicillin; Bacteremia; Child, Preschool; Chloramphenicol; Community-Acquired Infections; Developing | 2008 |
Efficacy, safety, and tolerance of piperacillin/tazobactam compared to co-amoxiclav plus an aminoglycoside in the treatment of severe pneumonia.
Topics: Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Commu | 1998 |
36 other studies available for gentamicin and Community Acquired Infection
| Article | Year |
|---|---|
Enterobacter agglomerans, an uncommon cause of community-acquired bacterial infection in neonates.
Topics: Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Community-Acquired Infections; Enterobac | 2022 |
Antibiotic treatment with one single dose of gentamicin at admittance in addition to a β-lactam antibiotic in the treatment of community-acquired bloodstream infection with sepsis.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Bacteremia; Bacteria; beta-Lactams; Community-Acqu | 2020 |
Is gentamicin safe and effective for severe community-acquired pneumonia? An 8-year retrospective cohort study.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Community-Acquired Infe | 2018 |
Treatment of community-acquired pneumonia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Femal | 2018 |
Risk factors for gentamicin-resistant E. coli in children with community-acquired urinary tract infection.
Topics: Anti-Bacterial Agents; beta-Lactamases; Case-Control Studies; Child, Preschool; Community-Acquired I | 2019 |
Use of gentamicin for women with community-acquired uncomplicated acute pyelonephritis caused by gentamicin-susceptible or -resistant Escherichia coli: 10-year experience.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Community-Acquired Infections; Drug Resistance, Bacteri | 2013 |
Antibiograms from community-acquired uropathogens in Gulu, northern Uganda--a cross-sectional study.
Topics: Adolescent; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacte | 2013 |
[Community-acquired methicillin-resistant Staphylococcus aureus endocarditis due to the emerging Géraldine clone: a challenging microbiological diagnosis].
Topics: Adult; Anti-Bacterial Agents; Bacterial Typing Techniques; Communicable Diseases, Emerging; Communit | 2013 |
Susceptibility to antibiotics of aerobic bacteria isolated from community acquired secondary peritonitis in children: therapeutic guidelines might not always fit with and everyday experience.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Child; Community-Acquired Inf | 2013 |
Effects of gentamicin monotherapy for the initial treatment of community-onset complicated non-obstructive acute pyelonephritis due to Enterobacteriaceae in elderly and non-elderly women.
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Community-Acquired Infections; Enterobacteriaceae I | 2014 |
Clinical manifestations and prognostic factors of Morganella morganii bacteremia.
Topics: Age Factors; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bacteremia; Cephalosporins; | 2015 |
Community-acquired urinary tract infection in hospitalized children: etiology and antimicrobial resistance. A comparison between first episode and recurrent infection.
Topics: Anti-Bacterial Agents; Cefazolin; Cefuroxime; Child, Hospitalized; Child, Preschool; Community-Acqui | 2015 |
Recognition of USA300 isolates of community-acquired methicillin-resistant Staphylococcus aureus in Australia.
Topics: Adult; Anti-Bacterial Agents; Australia; Community-Acquired Infections; Gentamicins; Humans; Male; M | 2008 |
[Septic pylephlebitis associated with Enterobacter cloacae septicemia].
Topics: Abdominal Pain; Adult; Anti-Bacterial Agents; Anticoagulants; Bacteremia; Ceftriaxone; Community-Acq | 2010 |
Clinical, molecular and epidemiological description of a cluster of community-associated methicillin-resistant Staphylococcus aureus isolates from injecting drug users with bacteraemia.
Topics: Adult; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactams; Community-Acquired Infectio | 2010 |
Increasing role of Staphylococcus aureus and community-acquired methicillin-resistant Staphylococcus aureus infections in the United States: a 10-year trend of replacement and expansion.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Ciprofloxacin; Community-Acquired Infections; Data | 2011 |
Short-term gentamicin therapy and risk of renal toxicity in patients with bacteraemia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cohort Studies; Community-Acquired Infec | 2011 |
An 11-year analysis of the prevalent uropathogens and the changing pattern of Escherichia coli antibiotic resistance in 38,530 community urinary tract infections, Dublin 1999-2009.
Topics: Adolescent; Adult; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; | 2013 |
In vitro killing of community-associated methicillin-resistant Staphylococcus aureus with drug combinations.
Topics: Community-Acquired Infections; Drug Synergism; Drug Therapy, Combination; Gentamicins; Humans; Kinet | 2004 |
Resistance development in community-acquired strains of methicillin-resistant Staphylococcus aureus: an in vitro study.
Topics: Community-Acquired Infections; Drug Resistance, Multiple; Gentamicins; Humans; Methicillin Resistanc | 2004 |
Pseudomonas aeruginosa infective endocarditis presenting as bacterial meningitis.
Topics: Acyclovir; Ampicillin; Calcification, Physiologic; Cefepime; Cephalosporins; Community-Acquired Infe | 2005 |
Detection of methicillin-resistant Staphylococcus aureus strains resistant to multiple antibiotics and carrying the Panton-Valentine leukocidin genes in an Algiers hospital.
Topics: Algeria; Alleles; Anti-Bacterial Agents; Bacterial Toxins; Community-Acquired Infections; Drug Resis | 2006 |
Molecular epidemiology of multiresistant Escherichia coli isolates from community-onset urinary tract infections in Cornwall, England.
Topics: beta-Lactamases; Community-Acquired Infections; Disease Outbreaks; Drug Resistance, Multiple, Bacter | 2007 |
Enterococcal bacteraemia: epidemiological, microbiological, clinical and prognostic characteristics, and the impact of high level gentamicin resistance.
Topics: Adult; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Community-Acquired Infections; Cross In | 2006 |
Recognition and treatment of neonatal community-associated MRSA pneumonia and bacteremia.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacteremia; Community-Acquired Infections; Drug Admini | 2008 |
Community-acquired enterococcal meningitis in an adult.
Topics: Adult; Ampicillin; Community-Acquired Infections; Enterococcus faecalis; Gentamicins; Gram-Positive | 1995 |
Community-acquired Pseudomonas aeruginosa infection in an infant.
Topics: Anti-Bacterial Agents; Bacteremia; Community-Acquired Infections; Gentamicins; Humans; Infant; Kwash | 1996 |
Severe community-acquired pneumonia caused by atypical organisms.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefuroxime | 1997 |
Epidemiologic evaluation of antimicrobial resistance in community-acquired enterococci.
Topics: Adult; Aged; Aged, 80 and over; Ampicillin Resistance; Anti-Bacterial Agents; Carrier State; Communi | 1998 |
Subcutaneous nodules with pseudomonas septicaemia in an immunocompetent patient.
Topics: Adult; Ceftazidime; Cephalosporins; Community-Acquired Infections; Female; Gentamicins; Humans; Immu | 1999 |
Increase in sepsis due to multi-resistant enteric gram-negative bacilli in Papua New Guinea.
Topics: Anti-Bacterial Agents; Chloramphenicol; Community-Acquired Infections; Drug Resistance, Multiple; Ge | 1999 |
Methicillin resistance among Trinidadian isolates of community and hospital strains of Staphylococcus aureus and their patterns of resistance to non-beta-lactam antibiotics.
Topics: Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Microbial; Erythromy | 1999 |
A community pseudo-outbreak of invasive Staphylococcus aureus infection.
Topics: Adolescent; Anti-Bacterial Agents; Cefazolin; Clindamycin; Community-Acquired Infections; Disease Ou | 2000 |
Community acquisition of gentamicin-sensitive methicillin-resistant Staphylococcus aureus in southeast Queensland, Australia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; Community-Acquired Infe | 2000 |
Resistance to vancomycin, LY333328, ciprofloxacin and trovafloxacin of community-acquired and nosocomial strains of Enterococcus faecalis isolated in Badajoz (Spain) with and without high-level resistance to streptomycin and gentamicin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Community-Acquired Infections; Cross In | 2001 |
Ototoxicity induced by gentamicin and furosemide.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Diuretics; Drug Synergism; Female; Furosemide; | 2002 |